Alex Aliper serves as the President of Insilico Medicine, a biotech research firm in Hong Kong SAR specializing in the use of artificial intelligence for drug discovery and aging research. His prior role as a research associate at the Center for Pediatric Hematology, Oncology, and Immunology provided him with substantial scientific experience. Under his leadership, Insilico Medicine is making stri...